NCT00576277View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

November 30, 2007

Conditions
Diabetic Neuropathy
Interventions
DRUG

AV411

Trial Locations (2)

Unknown

University of Adelaide, Adelaide

Peninsular Specialist Centre, Kipparing

Sponsors

Lead Sponsor

Avigen
All Listed Sponsors
lead

Avigen

INDUSTRY

NCT00576277 - Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain | Biotech Hunter | Biotech Hunter